This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ambrx, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jinming Xia: Innovator in Antibody Drug Conjugates
Introduction
Jinming Xia is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of biotechnology, particularly in the development of antibody drug conjugates. His work focuses on innovative solutions for treating prostate-specific membrane antigen (PSMA) related diseases.
Latest Patents
Jinming Xia holds a patent for "Humanized anti-prostate-specific membrane antigen (PSMA) antibody drug conjugates." This invention relates to humanized antibodies targeting PSMA and the development of anti-PSMA antibody drug conjugates. The patent also encompasses methods and compositions for utilizing these conjugates in inhibiting, preventing, or treating PSMA-related diseases or cancers. He has 1 patent to his name.
Career Highlights
Jinming Xia is currently associated with Ambrx, Inc., where he continues to advance his research and development efforts. His work has the potential to significantly impact the treatment landscape for prostate cancer and related conditions.
Collaborations
Some of his notable coworkers include Shivarupam Bhowmik and Jianing Wang, who contribute to the collaborative environment at Ambrx, Inc.
Conclusion
Jinming Xia's innovative work in the field of antibody drug conjugates exemplifies the potential of biotechnology to address critical health challenges. His contributions are paving the way for new therapeutic options in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile